Abstract
T cell response precedes serological response, and is more feasible than pathogen detection by molecular tools. Thus, monitoring T cell response to class-A pathogens may allow for a timely treatment and a correct handling of patients containment issues, after exposure to potentially lethal agents, such as biological threat, or emerging pathogens. In this paper, we describe a procedure for the evaluation of T cell response to microbial pathogens, including class-A pathogens in BSL-3 and BSL-4 equipped laboratories.
